Focus on Anticoagulation Care

Back to articles

Specialized Care Needed for Atrial Fibrillation, Venous Disorders

KEY POINT

For patients with atrial fibrillation (AF), researchers are looking for cures, but the search is a difficult one. Anticoagulation services—usually provided by pharmacists—remain important in making sure that the right patients receive the right drugs at the right doses so that venous complications of AF are prevented.

SOURCES

Scheinman MM. Mechanisms of atrial fibrillation: is a cure at hand? J Am Coll Cardiol. 2000;35:1687–92.

Samsa GP et al. Quality of anticoagulation management among patients with atrial fibrillation. Arch Intern Med. 2000;160:967–73. .

Li-Saw-Hee FL et al. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation. Stroke. 2000;31:828–33.

Yamaguchi T et al. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Stroke. 2000;31:817–21.

Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295–302.

Sors H, Meyer G. Place of aspirin in prophylaxis of venous thromboembolism [editorial]. Lancet. 2000;355:1288–9.

Kalra L et al. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ. 2000;320:1236–9.